Clinical Trials Browser

Has results × brigatinib × 1 year × Clear all

NCT03737994 2026-04-23

Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer

Phase 2 Terminated

10 enrolled 17 charts

Lung Neoplasms

NCT03596866 2025-09-12

ALTA-3

Phase 3 Completed

248 enrolled 20 charts

ALK+ Advanced NSCLC

NCT03535740 2025-07-31

ALTA-2

Phase 2 Completed

103 enrolled 23 charts

ALK-positive Advanced NSCLC